TABLE 3.
Neutralization of molecularly cloned and uncloned HIV-1 MN and NR variant E4
| Human serum | Reciprocal of NA titer against virus pool prepared froma:
|
|||
|---|---|---|---|---|
| MN
|
E4
|
|||
| Uncloned | Cloned | Uncloned | Cloned | |
| Reference 1 | >5,120 | 80 | 8 | 8 |
| Reference 2 | >5,120 | 320 | 32 | 128 |
| NY-3 | >5,120 | 80 | 8 | <8 |
| NY-4 | >5,120 | 160 | <8 | NTb |
| NY-5 | >5,120 | 80 | <8 | 16 |
| NY-9 | >5,120 | 1,280 | 256 | NT |
| L-1 | >5,120 | 80 | 8 | 32 |
| L-4 | 5,120 | 640 | 128 | 128 |
| L-5 | >5,120 | 640 | 64 | 64 |
a
In assays using the MN virus, sera were tested in serial twofold dilutions beginning at an initial dilution of 1:10, while in assays using the E4 virus, the starting dilution was 1:8.
b
NT, not tested.